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Abstract
Contemporary technology using mapping tools and 
algorithms in animal and computer models has suggested 
discrete atrial fibrillation (AF)-sustaining mechanisms in the 
form of electric rotors as focal areas of AF perpetuation. When 
these focal sites were targeted, ablation initially appeared 
promising in reducing the recurrence rates of AF. However, 
many other investigators have been unable to reproduce this kind 
of success with focal impulse and rotor modulation (FIRM)-
guided ablation, and have cast doubts on the effectiveness of this 
novel technique that could have led to a paradigm-shift in our 
approach to AF ablation. A single randomized trial that was 
recently published in a high-impact cardiology journal indicating 
poor results of rotor ablation was subsequently retracted amidst 
a cloud of controversy and doubt about the flaws and conflicts 
of current medical publishing. Thus, until further evidence from 
ongoing and future randomized studies becomes available, the 
target of focal ablation for AF patients continues to remain 
elusive. Rhythmos 2017;12(2):21-25.
Key Words: atrial fibrillation; acute atrial fibrillation; persistent 
atrial fibrillation; catheter ablation; rotors; focal impulses; focal 
fibrillation waves; pulmonary vein isolation 
Abbreviations: AF = atrial fribrillation; FIRM = focal impulse 
and rotor modulation; PV = pulmonary vein; PVI = pulmonary 
vein isolation
Introduction
Atrial fibrillation (AF) is the most common arrhythmia 
with continuously increasing trends in its incidence, 1
associated with increased morbidity and mortality and 
incurring high societal impact and financial cost. 2, 3
Rhythm control strategies with antiarrhythmic drugs have 
been disappointing, while the advent of ablation 
techniques has ushered in a new era in the management of 
this arrhythmia. 2-6 Current ablation methods comprise 
pulmonary vein (PV) isolation (PVI) techniques with 
either radiofrequency energy or cryoenergy application 
that may eliminate or limit the arrhythmia triggers. 2, 6, 7
These methods have been mainly proposed for paroxysmal 
AF, while for persistent or longstanding persistent AF, 
additional ablation steps targeting the arrhythmia substrate 
have been performed by several investigators. 8 However, 
even with the best available technological advancements, 
the efficacy of ablation is hampered by moderate success 
rates and increased number of complications. The ablation 
procedures are demanding lengthy and tedious, and are 
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still plagued by high recurrence rate,6 unlike the usual 
ablation procedures of other supraventricular or idiopathic 
ventricular tachycardias, which are routinely and 
practically cured with focal ablation with very high 
success, low complication and recurrence rates. 9 Thus, 
there has been a continuing search for a more effective way 
to approach this common arrhythmia with a similar 
strategy, however, to date this quest has not been very 
fruitful. 
The most important tool to investigate a possible focal 
approach to AF ablation can only be found by better 
understanding of its pathogenesis and pathophysiology 
mechanisms, which has certainly not been an easy task 
over the years. Modern and sophisticated technology using 
mapping tools and algorithms in animal and computer 
models has suggested discrete AF-sustaining mechanisms 
in the form of electric rotors spinning at high speed and 
producing gradients in the spatial distribution of dominant 
atrial frequencies, with the highest frequency domain 
corresponding to the rotor location. 10-12 When these high 
frequency domain sites were targeted, ablation initially 
appeared promising in reducing the recurrence rates of AF. 
13, 14
However, many other investigators have been unable to 
reproduce this kind of success with focal impulse and rotor 
modulation (FIRM)-guided ablation, and have cast doubts 
on the effectiveness of this novel technique that could lead 
to a paradigm-shift in our approach to AF ablation. 15, 16
Furthermore, other investigators have been insisting for a 
long time that localized rotors and focal impulse sources 
of AF are based on false premises, as they have never been 
able to prove their existence in their own experiments, as 
they could only visualize focal AF waves rapidly 
dispersing and without spatial stability. 17, 18
Rotors and Focal Impulses
It’s been quite a while since Jalife and colleagues have 
described rotor activity in optical mapping studies in 
experiments in isolated hearts, as well in computer 
simulation studies. 10 These investigators believe and 
assert that studies at the whole-heart level support the 
hypothesis that maintenance of both paroxysmal and 
persistent AF may depend on the periodic activity of a 
small number of rotors in the posterior left atrial wall-PV 
region. 11 These rotors activate the atria at exceedingly 
high frequencies and result in fibrillatory conduction. 
This idea of AF maintained by fibrillatory conduction 
emanating from a small number of high-frequency 
reentrant sources (rotors), was further supported by the 
work of Narayan and colleagues by developing a technique 
of rotor elimination as a therapeutic strategy for AF. 14
These investigators postulated that atrial rotor activity was 
critical in maintenance of ongoing fibrillatory activity, and 
could be identified and successfully ablated. They 
developed novel mapping techniques (Topera Solution, 
Abbott, Chicago) that allowed for the identification and 
localization of rotor sources. Initially, they recruited 92 
patients with paroxysmal or persistent (72%) AF 
undergoing 107 procedures and tested their technique 
followed by the conventional method in 27 patients and 
compared it with the conventional method alone applied in 
65 patients. 14 Localized rotors or focal impulses were 
detected in 98 (97%) of 101 procedures with sustained AF, 
each exhibiting 2.1 ± 1.0 sources. AF termination (in a 
median of 2.5 min) or slowing was achieved in 86% of 
focal impulse and rotor modulation (FIRM)-guided cases 
vs 20% of control cases (p < 0.001). Ablation time was 
similar in the two groups (52-58 min). During follow-up 
(median 9 months) after a single procedure, FIRM-guided 
cases had higher freedom from AF (82.4% vs 44.9%; p < 
0.001). Extended follow-up to 2.4 years indicated that 
patients receiving FIRM-guided ablation maintained 
higher freedom from AF after 1.2 ± 0.4 procedures 
(median 1) (77.8% vs 38.5%, p = 0.001) and a single 
procedure (p < 0.001) and higher freedom from all atrial 
arrhythmias (p = 0.003). 19 Thus, early clinical 
investigations of rotor elimination appeared quite 
promising. 14, 19, 20 Furthermore, the same investigators in a 
retrospective analysis of rotor sites in patients having PVI 
suggested the success of that procedure might in fact have 
been due to fortuitous elimination of rotors, rather than 
PVI per se. 21 These results were considered promising 
enough that industry rushed to embrace the strategy. 
Rotor Opposing Studies
Other investigators have consistently been opposing the 
idea of existing rotors as a pathogenetic mechanism in AF, 
22 while others have presented poor results of rotor ablation 
in clinical studies. 15, 16 Allessie and colleagues have 
mapped AF activity in a number of models, and have not 
seen AF-sustaining rotors refuting the findings described 
by Jalife et al, calling into question the basic 
pathophysiology in targeting such rotor or focal impulse 
sources during ablation.22 Instead of rotors as the drivers 
of AF, Allessie et al have observed by direct high-
resolution mapping of fibrillatory tissue a quite different 
physiology pointing into longitudinal dissociation of 
propagating wavefronts between epi- and endocardial 
atrial layers. 17 These investigators demonstrated many 
narrow wavelets propagating simultaneously through the 
atrial wall with their lateral boundaries formed by lines of 
interwave conduction block, predominantly oriented 
parallel to the atrial musculature. The highest degree of 
interwave conduction block was found in the PV area.
These investigators believe that electric dissociation of 
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neighboring atrial muscle bundles is a key element in the 
development of the substrate of human AF. 
In another study, the same investigators found focal 
fibrillation waves widely distributed over both atria (with 
the right atrium having ~4-fold higher incidence of focal 
waves in persistent than during acute AF). 18 The majority 
(90.5%) occurred as single events, while repetitive focal 
activity (>3) happened in only 0.8%. The authors believe 
that these data favor epicardial breakthrough rather than a 
cellular focal mechanism as the underlying mechanism. 
Often, conduction from a site of epicardial breakthrough 
was blocked in 1 or more directions. This generated 
separate multiple wave fronts propagating in different 
directions over the epicardium. They concluded that focal 
fibrillation waves are due to epicardial breakthrough of 
waves propagating in deeper layers of the atrial wall, 
providing a constant source of independent fibrillation 
waves originating over the entire epicardial surface, 
offering an adequate explanation for the high persistence 
of AF in patients with structural heart disease. 
Furthermore, a number of recent clinical studies have 
reported poor results in patients undergoing rotor ablation 
either as a stand-alone strategy or in conjunction with 
PVI.15, 16 Gianni et al reported their results of rotor ablation 
in 29 patients with persistent AF. Rotors were identified in 
all patients, with a mean of 4 ± 1.2 per patient (62% were 
left atrial). 15 All sources were successfully ablated, but 
overall acute success rate was 41% and short-term efficacy 
(mean 5.7 months) of a single-procedure with freedom 
from atrial arrhythmia without antiarrhythmic drugs was 
only 17%. 
Buch et al performed FIRM-guided ablation in 43 
patients treated for AF (56% paroxysmal, 67% having had 
prior AF ablation) at 2 academic medical centers, targeting 
rotors, along with PVI in 77% of patients. 16 They 
identified rotors in all patients (mean 2.6 ± 1.2 per patient, 
77% in left atrium), but acute procedural success was 47% 
with a 9.3% complication rate. At 18 ± 7 months of follow-
up, 37% were free from documented recurrent AF after a 
3-month blanking period; only 21% were free from 
documented atrial tachyarrhythmias and off 
antiarrhythmic drugs. 
On top of this big controversy, a recent event with a 
recalled randomized study came to stir the waters and 
instill more controversy and trigger wide discussion in the 
electrophysiology community about heavily conflicted 
interests (http://www.medscape.com/viewarticle/868778). OASIS 
(Outcome of Different Ablation Strategies In Persistent 
and Long-Standing Persistent Atrial Fibrillation)
(https://clinicaltrials.gov/ct2/show/NCT02533843?term=OASI
S&rank=15) was the first randomized study comparing 
three ablation strategies in persistent or long-standing 
nonparoxysmal AF that showed that targeting electrical 
rotors was associated with very poor results. It included 
113 patients from two US centers and one German center 
undergoing first-time AF ablation to FIRM-only (n=29; 
28% female), FIRM plus PVI (n=42; 33% female), or PVI 
plus posterior wall and non-PV trigger ablation (n=42; 
31% female). FIRM mapping was repeated until all rotors 
were identified and ablated or AF organized into atrial 
tachycardia or converted to sinus rhythm. Focal drivers or 
rotors were detected in all FIRM patients (mean 4 per 
patient FIRM-only; 4.2 FIRM-PVI). Rotor mapping and 
ablation prolonged the procedure duration, which averaged 
131 min with PVI plus posterior wall and non-PV trigger 
ablation vs 222 min with FIRM-alone and 233 min with 
FIRM plus PVI (P<0.001). No procedure-related adverse 
events occurred with FIRM-alone, but the arm was stopped 
early for futility after a relatively high rate of recurrence. 
At 12 months of follow-up, the primary end point of 
freedom from any recurrent atrial arrhythmias without 
antiarrhythmic drugs occurred in 14% of patients with 
FIRM-only, 52% with FIRM plus PVI, and 76% with 
standard PVI plus posterior wall and non-PV trigger 
ablation (log rank P<0.0001). The study results were 
presenting at a late breaking news session at the Heart 
Rhythm Society Meeting in 2016 
(http://www.medscape.com/viewarticle/863139) and was 
simultaneously published in the American College of 
Cardiology Journal, but was subsequently retracted 
(http://www.medscape.com/viewarticle/868778)
(http://www.sciencedirect.com/science/article/pii/S07351
09716328273). 23
Drivers of Intramural Reentry
Other investigators have put forth the theory of 
intramural reentry as the basic mechanism for AF 
maintenance. 24, 25 Based on ex vivo experimental results 
and clinical studies, they hypothesize that there exists 
localized intramural reentry that maintains AF in humans 
which is anchored to patient-specific microanatomic tracks 
of varying number, size, and distribution. They assert that 
there is a limited number of localized intramural 
microanatomic reentrant AF drivers anchored to heart-
specific 3-dimensional fibrotically insulated myobundle 
tracks, which remain hidden to current clinical single-
surface electrode mapping. They propose that 
simultaneous endocardial-epicardial mapping coupled 
with high-resolution 3D structural imaging may be able to 
reveal these drivers. 26 They believe that this theory may 
unify the findings from many clinical electrode mapping 
studies and that better understanding of microanatomic 
reentrant AF driver fingerprints could lead to more reliable 
identification of these drivers and targeted AF ablation 
strategies. 
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Current AF Ablation Techniques
 
Figure 1. The core of all AF ablation techniques is pulmonary 
vein isolation (PVI), whether AF is paroxysmal or persistent. 
PVI is effected via radiofrequency or cryoenergy application. 
However, many investigators have suggested and applied more 
extensive (adjunctive) ablation targeting the substrate in patients 
with persistent AF, including ablation of areas of complex 
fractionated atrial electrograms (CFAE) or ganglionated plexi 
(GP) (both considered cardiac autonomic denervation), ablation 
of the posterior wall (PW) and/or applying linear lesions in the 
left atrium. Current guidelines though recommend use of extra 
ablation techniques on top of complete PVI only upon 
recurrences of AF. With the advent of focal impulse and rotor 
modulation (FIRM)-guided ablation, hopes rose high that this 
type of focal ablation could be applied for all types of AF with 
or without PVI, however problems with reproducibility of 
initially promising results and lack of randomized trial results 
have curtailed initial enthusiasm. CFAE = complex fractionated 
atrial electrograms; cryo = cryoenergy; FIRM = focal impulse 
and rotor modulation; GP = ganglionated plexi; PAF = 
paroxysmal atrial fibrillation; persAF = persistent atrial 
fibrillation; PVI = pulmonary vein isolation; PW = posterior 
wall; RF = radiofrequency (energy)
Conclusion and Perspective
Pulmonary vein isolation (PVI) remains the 
cornerstone of all ablation techniques for patients with 
either paroxysmal or persistent AF (Fig. 1). Although from 
the beginning of AF ablation procedures, this was apparent 
for the paroxysmal type of AF, the RASTA (Randomized 
ablation strategies for the treatment of persistent atrial 
fibrillation) and STAR AF (Substrate and Trigger Ablation 
for Reduction of Atrial Fibrillation Trial - Star AF II 
Study) studies suggested that PVI alone is a best first step 
even for persistent AF. 27, 28 Other additional steps and 
adjunctive approaches to AF ablation, including testing 
for, and ablating macroreentrant flutter(s) and non-PV 
trigger sites, and/or targeting the arrhythmia substrate with 
linear ablation or ablation of complex fractionated atrial 
electrograms (CFAE) could be part of an individualized 
approach. 8, 29 Electrical and anatomic remodeling of the 
atria may be the at the core of the arrhythmia problem, and 
the degree of atrial fibrosis denoting the extent of 
anatomical remodeling (so called “fibrotic atrial 
cardiomyopathy”), which is harder to reverse as compared 
to reversible electrical remodeling, may determine the
success of ablation, at least for the cases of persistent AF. 
30
With regards to the utility of focal ablation of rotors or 
focal impulse areas or other drivers such as intramural 
reentry drivers, this remains a moot point at this juncture. 
Ongoing and future studies may offer more data on this 
issue. The REAFFIRM (Randomized Evaluation of Atrial 
Fibrillation Treatment With Focal Impulse and Rotor 
Modulation Guided Procedures) trial, estimated to finish 
in 2018, is an industry-sponsored, randomized, multicenter 
study comparing the efficacy of PVI + FIRM ablation to 
PVI alone (ClinicalTrials.gov; NCT02274857). Until then, 
great controversy clouds the efficacy of focal ablation for 
AF patients, and its target continues to remain elusive. 
REFERENCES
1. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in 
incidence of atrial fibrillation in Olmsted County, Minnesota, 
1980 to 2000, and implications on the projections for future 
prevalence. Circulation 2006;114:119-125.
2. Georgiopoulos G, Tsiachris D, Manolis AS. Cryoballoon 
ablation of atrial fibrillation: A practical and effective 
approach. Clin Cardiol 2016;Dec 19. doi: 
10.1002/clc.22653. [Epub ahead of print].
3. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC 
Guidelines for the management of atrial fibrillation 
developed in collaboration with EACTS: The Task Force for 
the management of atrial fibrillation of the ESC. Developed 
with the special contribution of the EHRA of the ESC,
Endorsed by the ESO. Eur Heart J 2016;37:2893-2962.
4. Calkins H, Kuck KH, Cappato R, et al. 2012 
HRS/EHRA/ECAS expert consensus statement on catheter 
and surgical ablation of atrial fibrillation: recommendations 
for patient selection, procedural techniques, patient 
management and follow-up, definitions, endpoints, and 
research trial design: a report of the HRS Task Force on 
Catheter and Surgical Ablation of Atrial Fibrillation. 
Developed in partnership with the EHRA, a registered branch 
of the ESC and the ECAS; and in collaboration with the 
ACC, AHA, the APHRS, and the STS. Endorsed by the 
governing bodies of the ACCF, the AHA, the ECAS, the 
PVI
(RF / Cryo)
CFAE / GP
ablation
(RF)
FIRM / Focal 
ablation
(RF)
PW/Linear/ 
Extra PV trigger
ablation
(RF)
25 
 
EHRA, the STS, the APHRS, and the HRS. Heart Rhythm
2012;9:632-696.e621.
5. Manolis AS. Rhythm or Rate Control Management of Atrial 
Fibrillation: An Overrated Dilemma. Hellenic J Cardiol
2015;56:495-500.
6. Manolis AS. Ablation of atrial fibrillation: single-shot 
techniques poised to dominate rhythm control strategies/the 
future is here. J Thorac Dis 2017;9:E313-321.
7. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous 
initiation of atrial fibrillation by ectopic beats originating in 
the pulmonary veins. N Engl J Med 1998;339:659-666.
8. Hussein AA, Barakat AF, Saliba WI, et al. Persistent Atrial 
Fibrillation Ablation With or Without Contact Force 
Sensing. J Cardiovasc Electrophysiol 2017 Feb 10. doi: 
10.1111/jce.13179. [Epub ahead of print].
9. Manolis AS, Wang PJ, Estes NA, 3rd. Radiofrequency 
catheter ablation for cardiac tachyarrhythmias. Ann Intern 
Med 1994;121:452-461.
10. Jalife J, Berenfeld O, Mansour M. Mother rotors and 
fibrillatory conduction: a mechanism of atrial fibrillation. 
Cardiovasc Res 2002;54:204-216.
11. Jalife J. Rotors and spiral waves in atrial fibrillation. J
Cardiovasc Electrophysiol 2003;14:776-780.
12. Pandit SV, Jalife J. Rotors and the dynamics of cardiac 
fibrillation. Circ Res 2013;112:849-862.
13. Atienza F, Almendral J, Jalife J, et al. Real-time dominant 
frequency mapping and ablation of dominant frequency sites 
in atrial fibrillation with left-to-right frequency gradients 
predicts long-term maintenance of sinus rhythm. Heart 
Rhythm 2009;6:33-40.
14. Narayan SM, Krummen DE, Shivkumar K, Clopton P, 
Rappel WJ, Miller JM. Treatment of atrial fibrillation by the 
ablation of localized sources: CONFIRM (Conventional 
Ablation for Atrial Fibrillation With or Without Focal 
Impulse and Rotor Modulation) trial. J Am Coll Cardiol
2012;60:628-636.
15. Gianni C, Mohanty S, Di Biase L, et al. Acute and early 
outcomes of focal impulse and rotor modulation (FIRM)-
guided rotors-only ablation in patients with nonparoxysmal 
atrial fibrillation. Heart Rhythm 2016;13:830-835.
16. Buch E, Share M, Tung R, et al. Long-term clinical outcomes 
of focal impulse and rotor modulation for treatment of atrial 
fibrillation: A multicenter experience. Heart Rhythm
2016;13:636-641.
17. Allessie MA, de Groot NM, Houben RP, et al. 
Electropathological substrate of long-standing persistent 
atrial fibrillation in patients with structural heart disease: 
longitudinal dissociation. Circ Arrhythm Electrophysiol
2010;3:606-615.
18. de Groot NM, Houben RP, Smeets JL, et al. 
Electropathological substrate of longstanding persistent 
atrial fibrillation in patients with structural heart disease: 
epicardial breakthrough. Circulation 2010;122:1674-1682.
19. Narayan SM, Baykaner T, Clopton P, et al. Ablation of rotor 
and focal sources reduces late recurrence of atrial fibrillation 
compared with trigger ablation alone: extended follow-up of 
the CONFIRM trial (Conventional Ablation for Atrial 
Fibrillation With or Without Focal Impulse and Rotor 
Modulation). J Am Coll Cardiol 2014;63:1761-1768.
20. Miller JM, Kowal RC, Swarup V, et al. Initial independent 
outcomes from focal impulse and rotor modulation ablation 
for atrial fibrillation: multicenter FIRM registry. J
Cardiovasc Electrophysiol 2014;25:921-929.
21. Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller 
JM. Direct or coincidental elimination of stable rotors or 
focal sources may explain successful atrial fibrillation 
ablation: on-treatment analysis of the CONFIRM trial 
(Conventional ablation for AF with or without focal impulse 
and rotor modulation). J Am Coll Cardiol 2013;62:138-147.
22. Allessie M, de Groot N. CrossTalk opposing view: Rotors 
have not been demonstrated to be the drivers of atrial 
fibrillation. J Physiol 2014;592:3167-3170.
23. Mohanty S, Gianni C, Mohanty P, et al. Impact of Rotor 
Ablation in Nonparoxysmal Atrial Fibrillation Patients: 
Results From the Randomized OASIS Trial. J Am Coll 
Cardiol 2016;68:274-282.
24. Hansen BJ, Csepe TA, Zhao J, Ignozzi AJ, Hummel JD, 
Fedorov VV. Maintenance of Atrial Fibrillation: Are 
Reentrant Drivers With Spatial Stability the Key? Circ 
Arrhythm Electrophysiol 2016;Oct;9(10). pii: e004398..
25. Csepe TA, Hansen BJ, Fedorov VV. Atrial fibrillation driver 
mechanisms: Insight from the isolated human heart. Trends 
Cardiovasc Med 2017;27:1-11.
26. Hansen BJ, Zhao J, Csepe TA, et al. Atrial fibrillation driven 
by micro-anatomic intramural re-entry revealed by 
simultaneous sub-epicardial and sub-endocardial optical 
mapping in explanted human hearts. Eur Heart J 2015; 36:
2390-2401.
27. Dixit S, Marchlinski FE, Lin D, et al. Randomized ablation 
strategies for the treatment of persistent atrial fibrillation: 
RASTA study. Circ Arrhythm Electrophysiol 2012;5:287-
294.
28. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter 
ablation for persistent atrial fibrillation. N Engl J Med 2015;
372:1812-1822.
29. Nademanee K, McKenzie J, Kosar E, et al. A new approach 
for catheter ablation of atrial fibrillation: mapping of the 
electrophysiologic substrate. J Am Coll Cardiol 2004; 43:
2044-2053.
30. Barbhayia CR, Kumar S, Michaud GF. Mapping Atrial 
Fibrillation: 2015 Update. J Atr Fibrillation 2015;8:1227.
